The administration of NAC (30,000 mg i.v. in 2 days) alleviated hemolysis and decreased COVID-19-associated increases in liver enzymes, C-reactive protein (CRP), and ferritin in the G6PD-deficient patient. The gene discussed is CRP; the disease is COVID-19.